- Cultivation Intent
You wish to cultivate medical cannabis in Rwanda. Rwanda's program is export-oriented — cultivation licenses are issued with the expectation that output will meet international (EU-GMP) standards for export markets.
- Export-oriented program
- EU-GMP target standard
- Rwanda FDA cultivation license required
- RDB Coordinates Application — Rwanda Development Board
RDB coordinates the investment and licensing process for cannabis cultivation. Facilitates engagement with Rwanda FDA and provides guidance on regulatory requirements.
- Investment proposal to RDB
- Business plan demonstrating export orientation
- Coordination with Rwanda FDA on licensing requirements
- Rwanda FDA Cultivation License
Rwanda FDA issues cultivation license after reviewing application, site assessment, and security arrangements. License specifies permitted cultivation area, varieties, and scope.
- Completed application to Rwanda FDA
- Site assessment and security plan
- GACP compliance plan
- Environmental impact assessment
- Processing: 3–6 months
- License granted?
Rwanda FDA reviews application against Ministerial Order requirements. May request additional site information, security arrangements, or GACP documentation.
- Address Rwanda FDA Queries
Provide additional site details, security plans, or GACP documentation as requested.
- Respond within Rwanda FDA timeframe
- Updated site plans if required
- GACP/GMP Certification
Licensed cultivator must obtain GACP certification and work toward EU-GMP certification for export eligibility. Rwanda producers typically engage EU-based QPs for GMP certification.
- GACP certification (ISO 17065 body)
- EU-GMP certification pathway for export
- EU QP engagement for batch certification
- Licensed — Export Production Ready ✓
Cultivation license and GACP/GMP certification in hand. Producer eligible for Rwanda FDA export authorization to serve EU, UK, and other international markets.